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ABSTRACT 
 
A simple, precise, and accurate RP-HPLC method has been developed and validated for the simultaneous assay of 
Paracetamol, Phenylpropanolamine and Triprolidinein tablet dosage form. Isocratic RP-HPLC method was 
developed on BDS hypersil C18, (250mm×4.6mm internal diameter, 5µ particle size) using mobile phase as Water 
(pH-4.0): Methanol (70:30v/v) at a flow rate of 1.0 mL/min and the detection was carried out at 220nm using 
tunable absorbance detector (Waters 486). Forced degradation study was carried out by acid degradation, base 
degradation, thermal degradation, oxidation of the drug. The method was validated for linearity, precision, accuracy 
and robustness. It was found to ideally resolve the peaks with retention time (RT) 4.053min,5.603min and 11.083 
min for Phenylpropanolamine, Paracetamol and Triprolidine respectively.The method was found to be linear in the 
concentration range of 50-150𝜇g/mL with correlation coefficient of 0.9994 for Paracetamol,2.5-7.5𝜇g/mL with 
correlation coefficient of 0.9995 for Phenylpropanolamineand 2.5-7.5𝜇g/mLwith correlation coefficient of 0.9992 
for Triprolidine. Degradation products produced as a result of stress studies did not interfere with the detection of 
Paracetamol, Phenylpropanolamine and Triprolidine; therefore, the assay can be considered to be stability 
indicating. 
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Introduction
Paracetamol’s empirical formula is C8H9NO2and its 
IUPAC name is N-(4-hydroxyphenyl) ethanamideN-
(4hydroxyphenyl) acetamide. Figure 1 shows chemical 
structure of Paracetamol. Paracetamol is organic 
compound containing an acetamide group conjugated 
to a phenyl group of Benzenoids group. Paracetamol is 
thought to act primarily in the CNS, increasing the pain 
threshold by inhibiting both isoforms of 
cyclooxygenase, COX-1, COX-2, and COX-3 enzymes 
involved in prostaglandin (PG) synthesis. 
Phenylpropanolamine’s empirical formula is C9H14NCl 
and its IUPAC name is (1S,2R)-2-amino-1-
phenylpropan-1-ol.  
____________________________ 
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Figure 2 shows chemical structure of 
Phenylpropanolamine. Phenylpropanolamine is a drug 
with adrenergic agonist properties. 
Phenylpropanolamine acts directly on alpha- and, to a 
lesser degree, beta-adrenergic receptors in the mucosa 
of the respiratory tract. Stimulation of alpha-adrenergic 
receptors produces vasoconstriction, reduces tissue 
hyperemia, edema, and nasal congestion, and increases 
nasal airway patency. It indirectly stimulates beta-
receptors, producing tachycardia and a positive 
inotropic effect. Triprolidine’s empirical formula is 
C19H22N2and its IUPAC name is 2-[(E)-1-(4-
methylphenyl)-3-pyrrolidin-1-yl-prop-1-enyl] 
pyridine.Figure 3 shows the chemical structure of 
Triprolidine.Triprolidine is first generation histamine 
H1 antagonist used in allergic rhinitis; asthma; and 
urticaria. It is a component of cough and cold 
medicines and may cause drowsiness Triprolidine 
binds to the histamine H1 receptor. This blocks the 
action of endogenous histamine, which subsequently 
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leads to temporary relief of the negative symptoms 
brought on by histamine. 
Literature survey reveals that quantitative analysis of 
Paracetamol, Phenylpropanolamine and Triprolidine 
have been done separately or in combination of two 
and in combination of other drugs but no method is 
reported for the simultaneous estimation of 
Paracetamol, Phenylpropanolamine and Triprolidinein 
combined dosage form. The present study involved the 
development and validation of RP-HPLC method for 
the estimation of Paracetamol, Phenylpropanolamine 
and Triprolidinein combined pharmaceutical dosage 
form (tablet) and their forced degradation study(1-3). 
 
Fig 1: Structure of Paracetamol 
 
Fig 2: Structure of Phenylpropanolamine 
 
Fig 3: Structure of Triprolidine 
 
Material and Methods 
Instruments 
The liquid chromatographic system consists of Waters 
series M510 equipped with a tunable absorbance 
detector (Waters 486), HPLC pump (Waters 510), and 
manual injector rheodyne valve with 20 𝜇L fixed loop. 
The analytes were monitored at 220 nm. 
Chromatographic analysis was performed on Thermo 
scientific BDS hypersil C18, (250mm × 4.6mm internal 
diameter, 5µ particle size). All the drugs and chemicals 
were weighed on Citizen electronic balance. Chemiline 
India pH meter and Toshcon Ultrasonicator was used. 
 
Chemicals and reagents 
Methanolwas of HPLC grade obtained from Merck 
Ltd., Mumbai. Water was of HPLC grade prepared by 
triple distillation method. Sodium Hydroxide (NaOH), 
Hydrogen Peroxide (H2O2) and Hydrochloric Acid 
(HCl) were of AR grade and were obtained from 
Merck, Mumbai India. Paracetamol reference standard, 
Phenylpropanolamine and Triprolidine reference 
standards were procured from Yash Pharma. Actifed 
Plus containing 100 mg of Paracetamol, 5mg of 
Phenylpropanolamine and 0.5mg of Triprolidine 
manufactured by Glaxo SmithKline Pharmaceuticals 
Ltdwas procured from local market. 
HPLC Conditions 
The mobile phase consisted of Water (pH-4.0): 
Methanol (70:30v/v).The mobile phase was prepared 
freshly and it was sonicated by using 
ToshconUltrasonicator for 5 min before use. BDS 
hypersil C18, (250mm×4.6mm internal diameter, 5µ 
particle size) was used and it was equilibrated for at 
least 30 min with the mobile phase flowing through the 
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system. The column and the HPLC system were kept at 
ambient temperature. The eluent was monitored by UV 
detection at 220 nm. Analysis was done at flowrate of 
1.0ml/min with 20μl volume of injection. All data were 
analyzed by using Empower 3 software. 
 
Preparation of Mobile Phase  
The mobile phase was prepared by mixing Water (pH-
4.0) and Methanol in the ratio of (70:30%v/v). The 
solution was then filtered through 0.45 microns 
membrane filter and degassed. 
 
Preparation of standard stock solution 
Standard stock solution of Paracetamol, 
Phenylpropanolamine and Triprolidinewere prepared 
by accurately weighing 100mg, 50mg and 50mg 
respectively and dissolving them separately in 100ml 
with methanol to prepare solution of 1000𝜇g/ml, 
50𝜇g/ml and 50𝜇g/ml.  
 
Preparation of working standard solution 
Add 1ml each of standard stock solution of 
Paracetamol, Phenylpropanolamine and Triprolidinein 
10 ml volumetric flask and volume make up to 10ml 
with methanol. 
 
Preparation of sample stock solution 
Weigh tablet powder equivalent to 5mg of 
Phenylpropanolamine, 100mg of Paracetamol and 
0.5mg of Triprolidine) into a 100ml volumetric flask. 
Add 60ml methanol andshake for 15 minutes. Make up 
volume with methanol upto 100ml. Filter this solution.  
 
Preparation of sample working solution 
Take 1ml from sample stock solution into a 10ml 
volumetric flask, add 1ml Triprolidine standard stock 
solution and make up with mobile phase to prepare a 
solution of Phenylpropanolamine 5mcg/ml, 
Paracetamol 100mcg/ml and Triprolidine 5.5mcg/ml 
(Triprolidine 0.5mcg+ Triprolidine standard 5mcg). 
 
Forced Degradation Study 
Preparation of solution for acid degradation  
Acid decomposition study was performed by keeping 
the working solution of all three drugs (1 ml) in 2 ml of 
0.1N HCl for 4 hrs. After 4hrs solution neutralized with 
2ml 0.1N NaOH and finally made up to 10 ml volume 
with mobile phase, sonicated and filtered through 
0.45μm membrane filter paper and injected in to HPLC 
system. Degradation samples were prepared as blank 
sample, separate standard samples and combined 
sample of all three drugs. 
 
Preparation of solution for basic degradation  
Alkali decomposition study was performed by keeping 
the working solution of all three drugs (1 ml) in 2 ml of 
0.1N NaOH for 4 hrs. After 4hrs solution neutralized 
with 2 ml of 0.1N HCL and finally made up to 10 ml 
volume with mobile phase, sonicated and filtered 
through 0.45μm membrane filter paper and injected in 
to HPLC system. Degradation samples were prepared 
as blank sample, separate standard samples and 
combined sample of all three drugs. 
 
Preparation of solution for oxidative degradation   
Oxidative decomposition study was performed by 
keeping the working solution of all three drugs (1 ml) 
in 2 ml 3% H2O2 for 5 hrs. After 5hrs volume made up 
to 10 ml with mobile phase,sonicated and filtered 
through 0.45μm membrane filter paper and injected 
into HPLC system. Degradation samples were prepared 
as blank sample, separate standard samples and 
combined sample of all three drugs. 
 
Preparation of solution for thermal degradation  
Thermal decomposition study was performed by 
refluxing the working solution of all three drugs (1 ml) 
for 24hrs at 105 ºC. After 24hrs volume made up to 10 
ml volume with mobile phase, sonicated and filtered 
through 0.45μm membrane filter paper and injected 
into HPLC system. Degradation samples were prepared 
as blank sample, separate standard samples and 
combined sample of all three drugs. 
 
Preparation of solution for UV degradation  
UV degradation was performed by exposing the 
working solution of all three drugs (1ml) to Sunlight 
for 24 hours. After 24 hours volume made up to 10 ml 
volume with mobile phase, sonicated and filtered 
through 0.45μm membrane filter paper and injected 
into HPLC system. Degradation samples were prepared 
as blank sample, separate standard samples and 
combined sample of all three drugs were prepared. 
 
Determination of λ max 
The UV spectra of standard stock solutions of 
Paracetamol, Phenylpropanolamine and Triprolidine 
were taken between the wave length range of 200-
400nm using methanol as blank. The λ max was found 
to be 245.93nm, 232.95nm and 183.31nm for 
Paracetamol, Phenylpropanolamine and Triprolidine 
respectively. Overlay of the three spectra taken and iso-
absorptive point was selected and it was found that all 
three drugs show appreciable absorbance at 220 nm, so 
it is used for the further study. 
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Fig 4: Overlay absorption spectrum for Paracetamol, Phenylpropanolamine and Triprolidine 
 
Procedure of Analysis 
1ml from Paracetamol Standard stock solution, 1ml 
from Phenylpropanolamine Standard stock solution and 
1ml from Triprolidine Standard stock solution were 
taken and volume was make up to 10ml with Mobile 
phase to obtain Working standard solution containing 
Paracetamol (100𝜇g/mL), Phenylpropanolamine 
(5𝜇g/mL) and Triprolidine(5𝜇g/mL). The contents of 
standard and sample solution were then filtered through 
0.45 µm syringe filter. Chromatograms standard 
solution (six replicates) was recorded. A typical 
chromatogram of Paracetamol, Phenylpropanolamine 
and Triprolidineis presented in figure 5. The retention 
time of Paracetamol, Phenylpropanolamine and 
Triprolidinewere 5.603 min, 4.653 min and 11.083min 
respectively. The peak areas were measured and the 
quantitation was carried out by keeping these values to 
the regression equation of calibration curve. 
 
Fig 5: Standard Chromatograms of Paracetamol, Phenylpropanolamine and Triprolidine 
 
Optimized Chromatographic Condition 
Stationary phase: Thermo scientific BDS hypersil C18 (250mm × 4.6mm, 5µ). 
Mobile phase  : Water (pH 4.0): Methanol (70:30 v/v) 
Flow rate   : 1.0 ml/min 
Run time (min) : 15min 
Detection  : At 220 nm 
Injection (volume)  : 20μl 
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Table 1: System suitability of proposed method 
Parameters Paracetamol Phenylpropanolamine Triprolidine 
Theoretical plates 7398 5839 7396 
Resolution - 3.769 14.122 
Asymmetry 1.398 1.563 1.366 
Retention time 5.603 min 4.653 min 11.083 min 
 
 
Method validation procedure 
The developed method was validated for the 
parameters listed in ICH guidelines (4-7). 
 
Linearity  
The method was linear in the range of 50-150𝜇g/mL, 
2.5-7.5 𝜇g/mL and 2.5-7.5𝜇g/mL for Paracetamol, 
Phenylpropanolamine and Triprolidine respectively. 
The linear correlation coefficient for Paracetamol, 
Phenylpropanolamine and Triprolidine were found to 
be 0.9994, 0.9995 and 0.9992 respectively, and are 
recorded in table 2, 3 and 4. Calibration curve of 
Paracetamol, Phenylpropanolamine and 
Triprolidinewas obtained by plotting the peak area ratio 
versus the respective concentrations (Figure 6, 7 and 
8).  
Table  2: Linearity results of Paracetamol 
 
Linearity Level Concentration Area 
I 50 µg/ml 4633.059 
II 75 µg/ml 7003.539 
III 100 µg/ml 9079.044 
IV 125 µg/ml 11424.241 
V 150 µg/ml 13463.017 
Correlation coefficient 0.9994 
 
Table 3: Linearity of Phenylpropanolamine 
 
Linearity Level Concentration Area 
I 2.5 µg/ml 1706.569 
II 3.75 µg/ml 2581.360 
III 5 µg/ml 3336.578 
IV 6.25 µg/ml 4209.745 
V 7.5 µg/ml 4981.000 
Correlation coefficient 0.9995 
 
Table 4: Linearity of Triprolidine 
Linearity Level Concentration Area 
I 2.5 µg/ml 495.645 
II 3.75 µg/ml 742.735 
III 5 µg/ml 977.866 
IV 6.25 µg/ml 1220.885 
V 7.5 µg/ml 1430.128 
Correlation coefficient 0.9992 
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Fig  6: Calibration curve of Paracetamol 
 
 
Fig  7: Calibration curve of Phenylpropanolamine 
 
 
Fig 8: Calibration curve of Triprolidine 
 
Accuracy  
The accuracy of the method was determined by 
recovery experiment and known concentration of 
working standard was added to the fixed concentration 
of the pre-analyzed tablet solution. Percent recovery 
was calculated by comparing the area before and after 
the addition of working standard and recovery was 
performed in the same way for all the three drugs. The 
recovery studies were performed in triplicate and 
results are recorded in table 5. This standard addition 
method was performed at 80%, 100%, 120% level and 
the percentage recovery was calculated. Percent 
recovery was within the range of 99.206-100.578 for 
Paracetamol, 98.923-99.943 for Phenylpropanolamine 
and99.727-100.308 for Triprolidinewhich indicates that 
the method was accurate. 
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Table 5: Results of Accuracy
 
Sample Accuracy Standard 
Drug(µg/ml) 
Sample Drug 
(µg/ml) 
% of recovery S.D. 
Paracetamol 80% 40 50 100.578 0.522 
100% 50 50 99.206 1.504 
120% 60 50 100.136  0.264 
Phenylpropanolamine 80% 2 2.5 99.943 0.971 
100% 2.5 2.5 98.923 1.268 
120% 3 2.5 99.894 0.439 
Triprolidine 80% 4 0.25 100.288 1.013 
100% 5 0.25 99.727 0.504 
120% 6 0.25 100.308 0.265 
 
Precision  
For the precision study, repeatability study was carried 
out for short time interval under the same 
chromatographic condition. The sample was injected in 
six replicates and peak area for all the six replicates 
was recorded. The mean and % relative standard 
deviation (%RSD) was calculated and the results are 
shown in table 6. The %RSD for Paracetamol, 
Phenylpropanolamine and Triprolidine were found to 
be 0.778%, 0.869% and 0.924 % respectively. From 
the data obtained the developed RP-HPLC method was 
found to be precise. For interday and intraday precision 
three different concentrations (50%, 100% and 150% 
of analyte) of standard solutions were injected on same 
day and three consecutive days in three replicates and 
results were recorded in table 7 & 8. 
 
Table  6: Results of Precision 
Injection Area of Paracetamol Area of Phenylpropanolamine Area of Triprolidine 
Injection 1 9122.124 3359.548 978.816 
Injection 2 9076.541 3335.379 975.895 
Injection 3 9017.960 3321.314 967.660 
Injection 4 9000.116 3309.954 967.635 
Injection 5 8999.830 3302.161 956.177 
Injection 6 8918.921 3275.594 958.962 
Average 9022.582 3317.325 967.524 
S.D. 70.156 28.811 8.941 
% RSD 0.778 0.869 0.924 
 
Table  7: Result of Interday Precision 
Conc. (µg/ml) Area % RSD 
Paracet
amol 
Phenylprop
anolamine 
Triprol
idine 
Paracetam
ol 
Phenylprop
anolamine 
Triprolidi
ne 
Paracetamol Phenyl
propan
olamine 
Tripr
olidin
e 
50 2.5 2.5 4528.097 1662.431 485.395 0.849 1.321 0.759 
100 5 5 9008.891 3312.439 969.738 0.579 0.607 0.554 
150 7.5 7.5 13594.07 4994.392 1461.311 1.034 1.144 0.902 
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Table 8: Result of Intraday Precision 
 
Conc. (µg/ml) Area % RSD 
Paracet
amol 
Phenylprop
anolamine 
Triproli
dine 
Paracetam
ol 
Phenylprop
anolamine 
Triprolidi
ne 
Paracet
amol 
Phenylprop
anolamine 
Tripro
lidine 
50 2.5 2.5 4528.097 1662.431 485.395 0.849 1.321 0.759 
100 5 5 9008.891 3312.439 969.738 0.579 0.607 0.554 
150 7.5 7.5 13594.07 4994.392 1461.311 1.034 1.144 0.902 
 
Limit of Detection (LOD) and Limit of 
Quantification (LOQ) 
The limit of detection and quantification were 
calculated using standard deviation of response and 
slope of the calibration curve and results are recorded 
table 9. The LOD for Paracetamol, 
Phenylpropanolamineand Triprolidine was found to be 
3.716 μg/ml, 0.174 μg/ml and 0.210 μg/ml 
respectively. The LOQ is the smallest concentration of 
the analyte, which gives response that can be 
accurately quantified. The LOQ for Paracetamol, 
Phenylpropanolamine and Triprolidinewas 11.261 
μg/ml, 0.529 μg/ml and 0.638μg/ml. 
Table  9: Results of LOD and LOQ 
Parameter Paracetamol (µg/ml) Phenylpropanolamine 
(µg/ml) 
Triprolidine(µg/ml) 
LOD 3.716 0.174 0.210 
LOQ 11.261 0.529 0.638 
 
Robustness 
Robustness of the method was checked by making 
slight deliberate changes in chromatographic 
conditions like flow rate, mobile phase ratio and pH of 
buffer and the result were recorded in table 10. It was 
observed that there were no marked changes in 
chromatograms and % relative standard deviation was 
found below 2%, which demonstrated that the 
developed RP-HPLC method is robust. 
Table 10: Results of Robustness 
 
Conditi
on 
Variatio
n 
Average Area % RSD 
Paracetam
ol 
Phenylpropan
olamine 
Triprolidin
e 
Paraceta
mol 
Phenylpropano
lamine 
Triprolidin
e 
Flow 
rate 
0.8 min 9546.055 3510.605 1022.257 0.216 0.332776 0.711444 
1.2 min 8691.59 3188.266 932.7417 0.251 0.62451 0.265757 
Mobile 
phase 
Water 
(pH 4.0): 
Methano
l (72:28 
v/v) 
8836.413  3247.385 947.9253 0.221 0.289671 0.541888 
Water 
(pH 4.0): 
Methano
l (68:32 
v/v) 
9366.981 3445.988 1004.45 0.694 0.885241 0.795956 
pH 6.2 9056.592 3322.327 973.375 0.352 0.633679 0.299421 
5.8 8877.534 3264.259 951.1223 0.462 0.423682 0.886248 
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Specificity 
The specificity of proposed method is justified by the 
chromatograms of blank, placebo, standard and sample 
solutions under same chromatographic conditions 
shown in figure 9. The placebos did not interfere in 
determination of Paracetamol, Phenylpropanolamine 
and Triprolidinein commercial tablet. Specificity of the 
developed method was also evaluated by applying 
different stress conditions (oxidation, acid, base, 
thermal and photolytic) to Paracetamol, 
Phenylpropanolamine and Triprolidine tablet. 
 
 
 
 
(a) 
 
 
 
 
 
(b) 
 
 
 
 
 
(c) 
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(d) 
 
 
 
 
 
(e) 
 
 
 
 
(f) 
 
 
Fig 9: Chromatograms of (a) Blank, (b) Paracetamol, (c) Phenylpropanolamine,(d) Triprolidine, (e) Standard 
mixture and (f) Sample mixture 
 
Degradation Study 
From the results of forced degradation studies showed 
that these components do not remained intact under 
stressed conditions and hence special storage 
conditions should be provided for the dosage form. The 
specificity studies showed that the principle peaks were 
well resolved (peak purity 99.99%) and free from any 
interference from the degradation product. The stress 
conditions were applied and degraded products of all 
three drugs are compared and showed in table 11 and 
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chromatograms are in figure 10. From the stress studies 
it is concluded that substantial degradation of 
Paracetamol, Phenylpropanolamine and Triprolidine 
occurred in acid, basic, oxidative thermal and 
photolytic stress conditions. The degradation products 
(impurities) in addition to percent degradation under 
acid, base, oxidation, thermal and photolytic stresses 
have unique retention times (RT) to acidic stress (9 
impurities, RT: 4.670 min, 5.667 min, 7.527 min, 7.717 
min, 9.153 min and 9.633min, 10.457 min, 11.147 min 
and 12.513 min), basic stress (8 impurities, RT: 4.650 
min, 5.667 min, 6.807 min and 7.900 min, 9.647 min, 
10.487 min, 11.160 min and 12.653 min), oxidative 
stress (8impurities, RT: 3.810 min, 4.673 min, 5.627 
min, 7.840 min, 8.420 min, 9.623 min, 10.193 min and 
11.217 min), thermal stress (7 impurities, RT: 4.653 
min, 5.643 min, 7.027 min, 8.367 min. 9.490 min, 
10.007 min and 11.183 min) and photolytic stress (12 
impurities, RT: 4.650 min, 5.670 min, 6.443 min, 6.873 
min, 7.703 min, 8.300 min, 8.750 min, 9.777 min, 
10.540 min, 11.197 min, 12.740 minand 14.193 min). 
Degradation studies justified the method specificity for 
its intended application. 
 
 
 
Table 11: Stability study results 
Type of 
degradation 
Drug Peak Area 
of 
Standard 
Conditions Peak area 
Standard Sample 
Area % Deg. Area % Deg. 
Acid 
degradation  
Paracetamol 9085.492 4 hours at 
Room 
Temperature 
7142.284 21.38803 7184.386 20.92463 
Phenylpropanola
mine 
3346.163 2778.715 16.96 2768.554 17.26 
Triprolidine 974.959 793.635 18.59812 801.740 17.767 
Base 
degradation  
Paracetamol 9085.492 4 hours at 
Room 
Temperature 
6301.313 30.64423 6394.391 29.61976 
Phenylpropanola
mine 
3346.163 2653.422 20.70 2594.504 22.46 
Triprolidine 974.959 780.623 19.93274 779.570 20.041 
Oxidative 
degradation  
Paracetamol 9085.492 5 hours at 
Room 
Temperature 
6136.852 32.45438 6288.912 30.78072 
Phenylpropanola
mine 
3346.163 2446.238 26.89 2478.91 25.92 
Triprolidine 974.959 745.265 23.55935 754.969 22.564 
Thermal 
degradation  
Paracetamol 9085.492 24 hours at 
1050C 
6331.444 30.31259 6372.831 29.85706 
Phenylpropanola
mine 
3346.163 2152.561 35.67 2192.828 34.47 
Triprolidine 974.959 623.33 36.06603 626.050 35.787 
Photolytic 
degradation  
Paracetamol 9085.492 24 hours in 
UV chamber 
7290.649 19.75504 7358.982 19.00293 
Phenylpropanola
mine 
3346.163 2818.476 15.77 2855.725 14.66 
Triprolidine 974.959 782.466 19.7437 775.488 20.459 
 
 
(a) 
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(b
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(c) 
 
(d) 
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(e) 
 
 
Fig 10: Chromatograms of (a) Acid Degradation, (b) Base Degradation (c) Oxidative Degradation, (d) 
Thermal Degradation, (e) Photolytic Degradation 
 
Results and Discussion 
 
To develop a new RP-HPLC method, several mobile 
phase compositions were tried. A satisfactory 
separation and good peak symmetry was obtained with 
BDS hypersil C18, 250mm×4.6mm internal diameter, 
5µ particle size or equivalent column and mobile phase 
comprising of Water (pH 4.0): Methanol (70:30v/v) at 
a flow rate of 1.0 ml/min to get better reproducibility 
and repeatability. Quantification was achieved with UV 
detection at 220nm based on peak area. The retention 
time for Paracetamol, Phenylpropanolamine and 
Triprolidine were found to be 5.603 min, 4.653 min 
and 11.083 min respectively. 
 
The optimized method was validated as per ICH 
guidelines. The system suitability parameters observed 
by using this optimized condition were reported. The 
method was found to be linear in the concentration 
range of 50-150 µg/mL with correlation coefficient of 
0.9994 for Paracetamol, 2.5-7.5 µg/mL with correlation 
coefficient of 0.9995 for Phenylpropanolamine, and 
2.5-7.5µg/mL with correlation coefficient of 0.9992 for 
Triprolidine. The results of recovery study (99.206% 
for Paracetamol,98.923% for Phenylpropanolamine 
and 99.727% for Triprolidine) suggest that the method 
has good recovery. The precision of the proposed 
method was carried in terms of the repeatability. The 
low% RSD (<2) values of 0.778%, 0.869% and 
0.924% variation for Paracetamol, 
Phenylpropanolamine and Triprolidine, respectively, 
reveals that the proposed method is precise. The LOD 
and LOQ values for Paracetamol were found to be 
3.716μg/ml and 11.261μg/ml, for 
Phenylpropanolamine were 0.174μg/ml and 
0.529μg/ml and for Triprolidine were 0.210μg/ml and 
0.638μg/ml. The results of robustness in the present 
method showed no significant changes. The results of 
analysis of drop indicated that no interference due to 
common excipients was observed with the developed 
method. Degradation studies justified the method 
specificity for its intended application. Therefore, the 
proposed method can be used for routine analysis of 
three drugs in their combined pharmaceutical dosage 
form. 
 
Conclusion 
 
A simple, precise, accurate and rapid method was 
developed for simultaneous estimation of Paracetamol, 
Phenylpropanolamine and Triprolidinefrom pure and 
its dosage forms. The mobile phase is simple to prepare 
and economical. The sample recoveries in the 
formulation were in good agreement with their 
respective label claims. Hence, this method can be 
easily and conveniently adopted for routine analysis of 
Paracetamol, Phenylpropanolamine and Triprolidinein 
pure form and its dosage form. 
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